Genomic determinants of homologous recombination deficiency across human cancers

Tao Qing, Xinfeng Wang, Tomi Jun, Li Ding, Lajos Pusztai, Kuan Lin Huang

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Germline BRCA1/2 mutations associated with HRD are clinical biomarkers for sensitivity to poly-ADP ribose polymerase inhibitors (PARPi) treatment in breast, ovarian, pancreatic, and prostate cancers. However, it remains unclear whether other mutations may also lead to HRD and PARPi sensitivity across a broader range of cancer types. Our goal was to determine the germline or somatic alterations associated with the HRD phenotype that might therefore confer PARPi sen-sitivity. Using germline and somatic genomic data from over 9000 tumors representing 32 cancer types, we examined associations between HRD scores and pathogenic germline variants, somatic driver mutations, and copy number deletions in 30 candidate genes involved in homologous re-combination. We identified several germline and somatic mutations (e.g., BRCA1/2, PALB2, ATM, and ATR mutations) associated with HRD phenotype in ovarian, breast, pancreatic, stomach, blad-der, and lung cancer. The co-occurrence of germline BRCA1 variants and somatic TP53 mutations was significantly associated with increasing HRD in breast cancer. Notably, we also identified multiple somatic copy number deletions associated with HRD. Our study suggests that multiple cancer types include tumor subsets that show HRD phenotype and should be considered in the future clinical studies of PARPi and synthetic lethality strategies exploiting HRD, which can be caused by a large number of genomic alterations.

Original languageEnglish
Article number4572
JournalCancers
Volume13
Issue number18
DOIs
StatePublished - Sep 2021

Keywords

  • Copy number variation
  • DNA damage repair
  • Germline and somatic
  • Homologous recombination

Fingerprint

Dive into the research topics of 'Genomic determinants of homologous recombination deficiency across human cancers'. Together they form a unique fingerprint.

Cite this